These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface. Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670 [TBL] [Abstract][Full Text] [Related]
3. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2). Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a. Kim TK; Park CS; Jang J; Kim MR; Na HJ; Lee K; Kim HJ; Heo K; Yoo BC; Kim YM; Lee JW; Kim SJ; Kim ES; Kim DY; Cha K; Lee TG; Lee S Mol Oncol; 2018 Mar; 12(3):356-372. PubMed ID: 29316206 [TBL] [Abstract][Full Text] [Related]
5. Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro. Ki MK; Jeoung MH; Choi JR; Rho SS; Kwon YG; Shim H; Chung J; Hong HJ; Song BD; Lee S Oncogene; 2013 Nov; 32(48):5449-57. PubMed ID: 23644659 [TBL] [Abstract][Full Text] [Related]
6. SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers. Zanivan S; Maione F; Hein MY; Hernández-Fernaud JR; Ostasiewicz P; Giraudo E; Mann M Mol Cell Proteomics; 2013 Dec; 12(12):3599-611. PubMed ID: 23979707 [TBL] [Abstract][Full Text] [Related]
7. CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis. Jang J; Kim MR; Kim TK; Lee WR; Kim JH; Heo K; Lee S Sci Rep; 2017 Sep; 7(1):10666. PubMed ID: 28878328 [TBL] [Abstract][Full Text] [Related]
8. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis. Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863 [TBL] [Abstract][Full Text] [Related]
9. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326 [TBL] [Abstract][Full Text] [Related]
10. The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis. Andreuzzi E; Colladel R; Pellicani R; Tarticchio G; Cannizzaro R; Spessotto P; Bussolati B; Brossa A; De Paoli P; Canzonieri V; Iozzo RV; Colombatti A; Mongiat M Matrix Biol; 2017 Dec; 64():40-53. PubMed ID: 28435016 [TBL] [Abstract][Full Text] [Related]
11. Clec14a genetically interacts with Etv2 and Vegf signaling during vasculogenesis and angiogenesis in zebrafish. Pociute K; Schumacher JA; Sumanas S BMC Dev Biol; 2019 Apr; 19(1):6. PubMed ID: 30953479 [TBL] [Abstract][Full Text] [Related]
13. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation. Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570 [TBL] [Abstract][Full Text] [Related]
14. An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours. Robinson J; Whitworth K; Jinks E; Nagy Z; Bicknell R; Lee SP J Pathol Clin Res; 2020 Oct; 6(4):308-319. PubMed ID: 32696621 [TBL] [Abstract][Full Text] [Related]
15. Type-H endothelial cell protein Clec14a orchestrates osteoblast activity during trabecular bone formation and patterning. Neag G; Lewis J; Turner JD; Manning JE; Dean I; Finlay M; Poologasundarampillai G; Woods J; Sahu MA; Khan KA; Begum J; McGettrick HM; Bellantuono I; Heath V; Jones SW; Buckley CD; Bicknell R; Naylor AJ Commun Biol; 2024 Oct; 7(1):1296. PubMed ID: 39394430 [TBL] [Abstract][Full Text] [Related]
16. Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Mura M; Swain RK; Zhuang X; Vorschmitt H; Reynolds G; Durant S; Beesley JF; Herbert JM; Sheldon H; Andre M; Sanderson S; Glen K; Luu NT; McGettrick HM; Antczak P; Falciani F; Nash GB; Nagy ZS; Bicknell R Oncogene; 2012 Jan; 31(3):293-305. PubMed ID: 21706054 [TBL] [Abstract][Full Text] [Related]
17. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation. Khan KA; McMurray JL; Mohammed F; Bicknell R FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944 [TBL] [Abstract][Full Text] [Related]
18. Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion. Rho SS; Choi HJ; Min JK; Lee HW; Park H; Park H; Kim YM; Kwon YG Biochem Biophys Res Commun; 2011 Jan; 404(1):103-8. PubMed ID: 21095181 [TBL] [Abstract][Full Text] [Related]
19. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium. Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033 [TBL] [Abstract][Full Text] [Related]
20. Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein. Sandoval DR; Gomez Toledo A; Painter CD; Tota EM; Sheikh MO; West AMV; Frank MM; Wells L; Xu D; Bicknell R; Corbett KD; Esko JD J Biol Chem; 2020 Feb; 295(9):2804-2821. PubMed ID: 31964714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]